Barclays Lowers CVS Health (NYSE:CVS) Price Target to $79.00
CVS Health (NYSE:CVS – Get Free Report) had its price objective reduced by stock analysts at Barclays from $82.00 to $79.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has an “overweight” rating on the pharmacy operator’s stock. Barclays‘s price objective indicates a potential upside of 24.17% from the stock’s current […]
CVS Health (NYSE:CVS – Get Free Report) had its price objective reduced by stock analysts at Barclays from $82.00 to $79.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has an “overweight” rating on the pharmacy operator’s stock. Barclays‘s price objective indicates a potential upside of 24.17% from the stock’s current […]
